Minigulov N, Boranbayev K, Bekbossynova A, Gadilgereyeva B, Filchakova O
Front Cell Infect Microbiol. 2024; 14:1458383.
PMID: 39711780
PMC: 11659265.
DOI: 10.3389/fcimb.2024.1458383.
Xue W, Chu H, Wang J, Sun Y, Qiu X, Song C
PLoS Pathog. 2024; 20(11):e1012097.
PMID: 39602452
PMC: 11633972.
DOI: 10.1371/journal.ppat.1012097.
Shi K, Hu X, Long F, Shi Y, Pan Y, Feng S
Front Microbiol. 2024; 15:1474552.
PMID: 39444682
PMC: 11496168.
DOI: 10.3389/fmicb.2024.1474552.
Botova M, Camacho-Zarco A, Tognetti J, Bessa L, Guseva S, Mikkola E
Sci Adv. 2024; 10(31):eaax2323.
PMID: 39093972
PMC: 11296341.
DOI: 10.1126/sciadv.aax2323.
Patarca R, Haseltine W
Int J Mol Sci. 2024; 25(6).
PMID: 38542351
PMC: 10970485.
DOI: 10.3390/ijms25063378.
SARS-CoV-2 outbreak: role of viral proteins and genomic diversity in virus infection and COVID-19 progression.
Hussein H, Thabet A, Wardany A, El-Adly A, Ali M, Hassan M
Virol J. 2024; 21(1):75.
PMID: 38539202
PMC: 10967059.
DOI: 10.1186/s12985-024-02342-w.
Epitopes recognition of SARS-CoV-2 nucleocapsid RNA binding domain by human monoclonal antibodies.
Kim Y, Maltseva N, Tesar C, Jedrzejczak R, Endres M, Ma H
iScience. 2024; 27(2):108976.
PMID: 38327783
PMC: 10847736.
DOI: 10.1016/j.isci.2024.108976.
Molecular mechanisms and cellular functions of liquid-liquid phase separation during antiviral immune responses.
Yang S, Shen W, Hu J, Cai S, Zhang C, Jin S
Front Immunol. 2023; 14:1162211.
PMID: 37251408
PMC: 10210139.
DOI: 10.3389/fimmu.2023.1162211.
Suramin Disturbs the Association of the N-Terminal Domain of SARS-CoV-2 Nucleocapsid Protein with RNA.
Guo C, Xu H, Li X, Yu J, Lin D
Molecules. 2023; 28(6).
PMID: 36985506
PMC: 10051649.
DOI: 10.3390/molecules28062534.
Emerging trends in point-of-care biosensing strategies for molecular architectures and antibodies of SARS-CoV-2.
Karuppaiah G, Vashist A, Nair M, Veerapandian M, Manickam P
Biosens Bioelectron X. 2023; 13:100324.
PMID: 36844889
PMC: 9941073.
DOI: 10.1016/j.biosx.2023.100324.
Targeting intracellular Neu1 for coronavirus infection treatment.
Yang D, Wu Y, Turan I, Keil J, Li K, Chen M
iScience. 2023; 26(2):106037.
PMID: 36714013
PMC: 9870608.
DOI: 10.1016/j.isci.2023.106037.
Liquid-liquid phase separation of nucleocapsid proteins during SARS-CoV-2 and HIV-1 replication.
Chau B, Chen V, Cochrane A, Parent L, Mouland A
Cell Rep. 2023; 42(1):111968.
PMID: 36640305
PMC: 9790868.
DOI: 10.1016/j.celrep.2022.111968.
Structural domains of SARS-CoV-2 nucleocapsid protein coordinate to compact long nucleic acid substrates.
Morse M, Sefcikova J, Rouzina I, Beuning P, Williams M
Nucleic Acids Res. 2022; 51(1):290-303.
PMID: 36533523
PMC: 9841419.
DOI: 10.1093/nar/gkac1179.
Anticipating the Next Chess Move: Blocking SARS-CoV-2 Replication and Simultaneously Disarming Viral Escape Mechanisms.
Casseb S, Khayat A, de Souza J, de Oliveira E, Dos Santos S, da Costa Vasconcelos P
Genes (Basel). 2022; 13(11).
PMID: 36421821
PMC: 9690012.
DOI: 10.3390/genes13112147.
Identification and characterization of alternative sites and molecular probes for SARS-CoV-2 target proteins.
Iyengar S, Barnsley K, Vu H, Bongalonta I, Herrod A, Scott J
Front Chem. 2022; 10:1017394.
PMID: 36385993
PMC: 9659918.
DOI: 10.3389/fchem.2022.1017394.
Zebrafish models of COVID-19.
Tyrkalska S, Candel S, Pedoto A, Garcia-Moreno D, Alcaraz-Perez F, Sanchez-Ferrer A
FEMS Microbiol Rev. 2022; 47(1).
PMID: 36323404
PMC: 9841970.
DOI: 10.1093/femsre/fuac042.
Host protein kinases required for SARS-CoV-2 nucleocapsid phosphorylation and viral replication.
Yaron T, Heaton B, Levy T, Johnson J, Jordan T, Cohen B
Sci Signal. 2022; 15(757):eabm0808.
PMID: 36282911
PMC: 9830954.
DOI: 10.1126/scisignal.abm0808.
The Role of Disordered Regions in Orchestrating the Properties of Multidomain Proteins: The SARS-CoV-2 Nucleocapsid Protein and Its Interaction with Enoxaparin.
Schiavina M, Pontoriero L, Tagliaferro G, Pierattelli R, Felli I
Biomolecules. 2022; 12(9).
PMID: 36139141
PMC: 9496478.
DOI: 10.3390/biom12091302.
Recent advances in applying G-quadruplex for SARS-CoV-2 targeting and diagnosis: A review.
Zhai L, Su A, Liu J, Zhao J, Xi X, Hou X
Int J Biol Macromol. 2022; 221:1476-1490.
PMID: 36130641
PMC: 9482720.
DOI: 10.1016/j.ijbiomac.2022.09.152.
Equine Anti-SARS-CoV-2 Serum (ECIG) Binds to Mutated RBDs and N Proteins of Variants of Concern and Inhibits the Binding of RBDs to ACE-2 Receptor.
Andrade S, Batalha-Carvalho J, Curi R, Wen F, Covas D, Chudzinski-Tavassi A
Front Immunol. 2022; 13:871874.
PMID: 35898497
PMC: 9310548.
DOI: 10.3389/fimmu.2022.871874.